CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-02 | Gelder Mark S. MD Chief Medical Officer | Grant or award · Restricted Stock Units | +13,950 | 13,950 | ||
| 2021-08-02 | Guerin Mark Patrick Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +42,750 | 42,750 | ||
| 2021-08-02 | Guerin Mark Patrick Chief Financial Officer | Grant or award · Restricted Stock Units | +14,250 | 14,250 | ||
| 2021-08-02 | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel | Grant or award · Stock Option (right to purchase) | +40,000 | 40,000 | ||
| 2021-08-02 | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel | Grant or award · Restricted Stock Units | +13,400 | 13,400 | ||
| 2021-07-30 | STOVER JACK E Director | Grant or award · Stock Option (right to purchase) | +13,000 | 13,000 | ||
| 2021-07-30 | Shoemaker Mary Teresa Director | Grant or award · Stock Option (right to purchase) | +13,000 | 13,000 | ||
| 2021-07-30 | MEHTA VIREN Director | Grant or award · Stock Option (right to purchase) | +13,000 | 13,000 | ||
| 2021-07-30 | MARINO JAMES J Director | Grant or award · Stock Option (right to purchase) | +13,000 | 13,000 | ||
| 2021-07-30 | GROOPMAN JEROME Director | Grant or award · Stock Option (right to purchase) | +13,000 | 13,000 | ||
| 2021-06-14 | Gelder Mark S. MD Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +20,000 | 20,000 | ||
| 2021-02-17 | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel | Grant or award · Stock Appreciation Right | +208,000 | 208,000 | ||
| 2021-02-17 | Guerin Mark Patrick Chief Financial Officer | Grant or award · Stock Appreciation Right | +301,000 | 301,000 | ||
| 2021-02-17 | Fruchtman Steven M President, Chief Executive Off | Grant or award · Stock Appreciation Right | +706,000 | 706,000 | ||
| 2021-02-16 | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel | Purchase | +12,000 | $1.00 | $12K | 152,000 |
| 2021-02-16 | Guerin Mark Patrick Chief Financial Officer | Purchase | +15,000 | $1.00 | $15K | 145,213 |
| 2021-02-16 | Fruchtman Steven M President, Chief Executive Off | Purchase | +20,000 | $1.00 | $20K | 236,226 |
| 2021-02-16 | MARINO JAMES J Director | Purchase | +25,000 | $1.00 | $25K | 230,716 |
| 2021-02-16 | Shoemaker Mary Teresa Director | Purchase | +13,000 | $1.00 | $13K | 50,735 |
| 2020-12-11 | OLER ABRAHAM N. SVP Corp Dev & Gen Counsel | Purchase | +30,000 | $0.32 | $10K | 140,000 |
Page 10 of 16 · 304 trades